The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Major Tranquilizers-Global Market Insights and Sales Trends 2025
Synopsis
Major tranquilizers are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
The global Major Tranquilizers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Major Tranquilizers in various end use industries. The expanding demands from the Schizophrenia, Bipolar Disorder, Unipolar Depression and Dementia, are propelling Major Tranquilizers market. First Generation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Second Generation segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Major Tranquilizers market, driven by demand from China, the second largest economy with some signs of stabilising, the Major Tranquilizers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Major Tranquilizers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Major Tranquilizers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Major Tranquilizers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Major Tranquilizers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Major Tranquilizers covered in this report include Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GSK and Allergan, etc.
The global Major Tranquilizers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Pfizer
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
GSK
Allergan
Global Major Tranquilizers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Major Tranquilizers market, Segment by Type:
First Generation
Second Generation
Third Generation
Global Major Tranquilizers market, by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Major Tranquilizers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Major Tranquilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Major tranquilizers are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
The global Major Tranquilizers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Major Tranquilizers in various end use industries. The expanding demands from the Schizophrenia, Bipolar Disorder, Unipolar Depression and Dementia, are propelling Major Tranquilizers market. First Generation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Second Generation segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Major Tranquilizers market, driven by demand from China, the second largest economy with some signs of stabilising, the Major Tranquilizers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Major Tranquilizers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Major Tranquilizers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Major Tranquilizers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Major Tranquilizers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Major Tranquilizers covered in this report include Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GSK and Allergan, etc.
The global Major Tranquilizers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Pfizer
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
GSK
Allergan
Global Major Tranquilizers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Major Tranquilizers market, Segment by Type:
First Generation
Second Generation
Third Generation
Global Major Tranquilizers market, by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Major Tranquilizers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Major Tranquilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Major Tranquilizers Market Overview
1.1 Major Tranquilizers Product Overview
1.2 Major Tranquilizers Market Segment by Type
1.2.1 First Generation
1.2.2 Second Generation
1.2.3 Third Generation
1.3 Global Major Tranquilizers Market Size by Type
1.3.1 Global Major Tranquilizers Market Size Overview by Type (2018-2029)
1.3.2 Global Major Tranquilizers Historic Market Size Review by Type (2018-2023)
1.3.3 Global Major Tranquilizers Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Major Tranquilizers Sales Breakdown by Type (2018-2023)
1.4.2 Europe Major Tranquilizers Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Major Tranquilizers Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Major Tranquilizers Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Major Tranquilizers Sales Breakdown by Type (2018-2023)
2 Global Major Tranquilizers Market Competition by Company
2.1 Global Top Players by Major Tranquilizers Sales (2018-2023)
2.2 Global Top Players by Major Tranquilizers Revenue (2018-2023)
2.3 Global Top Players by Major Tranquilizers Price (2018-2023)
2.4 Global Top Manufacturers Major Tranquilizers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Major Tranquilizers Market Competitive Situation and Trends
2.5.1 Major Tranquilizers Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Major Tranquilizers Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Major Tranquilizers as of 2022)
2.7 Date of Key Manufacturers Enter into Major Tranquilizers Market
2.8 Key Manufacturers Major Tranquilizers Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Major Tranquilizers Status and Outlook by Region
3.1 Global Major Tranquilizers Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Major Tranquilizers Historic Market Size by Region
3.2.1 Global Major Tranquilizers Sales in Volume by Region (2018-2023)
3.2.2 Global Major Tranquilizers Sales in Value by Region (2018-2023)
3.2.3 Global Major Tranquilizers Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Major Tranquilizers Forecasted Market Size by Region
3.3.1 Global Major Tranquilizers Sales in Volume by Region (2024-2029)
3.3.2 Global Major Tranquilizers Sales in Value by Region (2024-2029)
3.3.3 Global Major Tranquilizers Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Major Tranquilizers by Application
4.1 Major Tranquilizers Market Segment by Application
4.1.1 Schizophrenia
4.1.2 Bipolar Disorder
4.1.3 Unipolar Depression
4.1.4 Dementia
4.1.5 Others
4.2 Global Major Tranquilizers Market Size by Application
4.2.1 Global Major Tranquilizers Market Size Overview by Application (2018-2029)
4.2.2 Global Major Tranquilizers Historic Market Size Review by Application (2018-2023)
4.2.3 Global Major Tranquilizers Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Major Tranquilizers Sales Breakdown by Application (2018-2023)
4.3.2 Europe Major Tranquilizers Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Major Tranquilizers Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Major Tranquilizers Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Major Tranquilizers Sales Breakdown by Application (2018-2023)
5 North America Major Tranquilizers by Country
5.1 North America Major Tranquilizers Historic Market Size by Country
5.1.1 North America Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Major Tranquilizers Sales in Volume by Country (2018-2023)
5.1.3 North America Major Tranquilizers Sales in Value by Country (2018-2023)
5.2 North America Major Tranquilizers Forecasted Market Size by Country
5.2.1 North America Major Tranquilizers Sales in Volume by Country (2024-2029)
5.2.2 North America Major Tranquilizers Sales in Value by Country (2024-2029)
6 Europe Major Tranquilizers by Country
6.1 Europe Major Tranquilizers Historic Market Size by Country
6.1.1 Europe Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Major Tranquilizers Sales in Volume by Country (2018-2023)
6.1.3 Europe Major Tranquilizers Sales in Value by Country (2018-2023)
6.2 Europe Major Tranquilizers Forecasted Market Size by Country
6.2.1 Europe Major Tranquilizers Sales in Volume by Country (2024-2029)
6.2.2 Europe Major Tranquilizers Sales in Value by Country (2024-2029)
7 Asia-Pacific Major Tranquilizers by Region
7.1 Asia-Pacific Major Tranquilizers Historic Market Size by Region
7.1.1 Asia-Pacific Major Tranquilizers Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Major Tranquilizers Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Major Tranquilizers Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Major Tranquilizers Forecasted Market Size by Region
7.2.1 Asia-Pacific Major Tranquilizers Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Major Tranquilizers Sales in Value by Region (2024-2029)
8 Latin America Major Tranquilizers by Country
8.1 Latin America Major Tranquilizers Historic Market Size by Country
8.1.1 Latin America Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Major Tranquilizers Sales in Volume by Country (2018-2023)
8.1.3 Latin America Major Tranquilizers Sales in Value by Country (2018-2023)
8.2 Latin America Major Tranquilizers Forecasted Market Size by Country
8.2.1 Latin America Major Tranquilizers Sales in Volume by Country (2024-2029)
8.2.2 Latin America Major Tranquilizers Sales in Value by Country (2024-2029)
9 Middle East and Africa Major Tranquilizers by Country
9.1 Middle East and Africa Major Tranquilizers Historic Market Size by Country
9.1.1 Middle East and Africa Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Major Tranquilizers Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Major Tranquilizers Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Major Tranquilizers Forecasted Market Size by Country
9.2.1 Middle East and Africa Major Tranquilizers Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Major Tranquilizers Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Major Tranquilizers Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Johnson & Johnson Major Tranquilizers Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Major Tranquilizers Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Major Tranquilizers Products Offered
10.2.5 Pfizer Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Major Tranquilizers Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly Major Tranquilizers Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Company Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Major Tranquilizers Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bristol-Myers Squibb Major Tranquilizers Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Major Tranquilizers Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Major Tranquilizers Products Offered
10.5.5 AstraZeneca Recent Development
10.6 GSK
10.6.1 GSK Company Information
10.6.2 GSK Introduction and Business Overview
10.6.3 GSK Major Tranquilizers Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GSK Major Tranquilizers Products Offered
10.6.5 GSK Recent Development
10.7 Allergan
10.7.1 Allergan Company Information
10.7.2 Allergan Introduction and Business Overview
10.7.3 Allergan Major Tranquilizers Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Allergan Major Tranquilizers Products Offered
10.7.5 Allergan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Major Tranquilizers Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Major Tranquilizers Industrial Chain Analysis
11.4 Major Tranquilizers Market Dynamics
11.4.1 Major Tranquilizers Industry Trends
11.4.2 Major Tranquilizers Market Drivers
11.4.3 Major Tranquilizers Market Challenges
11.4.4 Major Tranquilizers Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Major Tranquilizers Distributors
12.3 Major Tranquilizers Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
